Trial on LRRK2 mutation in Parkinson’s disease is about to be completed.
Our Clinical Trials Unit is the lead international recruiter for this Phase 1 trial.
A hope for patients with Parkinson’s disease and this mutation. Keep informed!

Compartir:
CategoryUncategorized

No dude en llamarnos 1-+34 935 656 000